Clinical trial Recruiting at 7 sites Interventional Ages 18 to 75 Women only

Supportive care program for patients with non-metastatic breast cancer undergoing hormone therapy

Official title: Programme d'Éducation Thérapeutique et d'Accompagnement Infirmier Vers Les Soins de Support, Chez Les Patientes Sous Hormonothérapie Pour un Cancer du Sein Non métastatique

Run by Centre Hospitalier Emile Roux · NCT04794075 · Data updated 2026-11-12

This study is testing a supportive care program that combines education and phone check-ins to see if it helps women with non-metastatic breast cancer feel better while they are on hormone therapy.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexWomen only
Enrollment300 (estimated)
SponsorCentre Hospitalier Emile Roux
Academic / other
Drugs / interventionschemotherapy
Locations9 sites (Bourg-en-Bresse and 8 other locations)
StatusRecruiting
StartedAugust 9, 2021
Main results expectedAugust 2028
Study endsAugust 2029
Registry record updatedAugust 5, 2026
Trial IDNCT04794075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with non-metastatic breast cancer who are about to start adjuvant hormone therapy and can understand French.

Probably not a fit

Patients with metastatic cancer or those who have previously undergone hormone therapy are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a therapeutic education program combined with nursing support via phone follow-ups for patients receiving hormone therapy for non-metastatic breast cancer. The goal is to manage adverse events related to hormone therapy and enhance the quality of life for these patients during the first year of treatment. By providing personalized care and active listening, the program seeks to improve overall patient outcomes compared to conventional management alone.

Why it matters

Potential benefit: If successful, this program could significantly improve the management of side effects from hormone therapy, leading to better quality of life for patients.

How similar studies have gone: Other studies have shown positive outcomes with similar supportive care approaches, indicating potential for success in this program.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 18 to 75 years inclusive
* Patients with non-metastatic breast cancer for whom adjuvant hormone therapy (anti-oestrogen or anti-aromatase) is indicated, depending on the decision of the multidisciplinary consultation meeting.
* Performance status (ECOG) ≤ 2
* Patient able to read and understand French (common use)
* Patient with access to an internet connection (for collection of adverse events and responses to questionnaires on the electronic platform)
* Patient who has been informed and has given written consent to participate in the study
* Patient affiliated to the French social security system or equivalent

Exclusion Criteria:

* Patient with metastatic cancer (stage IV)
* Patient undergoing neoadjuvant hormone therapy
* Patient who started hormone therapy prior to inclusion in the study
* Patient with a history of other cancer treated by radiotherapy, chemotherapy or hormone therapy, with an end of treatment less than 2 years ago.
* For patients in the experimental group: Inability of the patient to travel to the hospital to attend the initial assessment day and the proposed group outpatient workshops; follow-up of the program difficult for geographical, physical or other reasons (at the discretion of the investigator).
* For patients in the control group: patients for whom telephone nursing follow-up is planned for 2 months or more or more than 4 sessions of therapeutic education.
* Pregnant and breastfeeding women
* Patient with a documented history of cognitive or psychiatric disorders
* Refusal to participate, protected adult patient, under guardianship or curatorship

Where it's running

  • Centre Hospitalier de Bourg-en-Bresse / Fleyriat
    Bourg-en-Bresse, France
    Recruiting
  • Clinique De L'infirmerie Protestante De Lyon
    Caluire-et-Cuire, France
    Recruiting
  • CH de Carcassonne
    Carcassonne, France
    Recruiting
  • Centre Hospitalier Emile Roux
    Le Puy-en-Velay, France
    Recruiting
  • Centre Hospitalier François Quesnay
    Mantes-la-Jolie, France
    Recruiting
  • Centre Hospitalier Universitaire de Saint-Étienne - Hôpital Nord
    Saint-Priest-en-Jarez, France
    Recruiting
Show 3 more locations
  • Médipôle Lyon-Villeurbanne
    Villeurbanne, France
    Recruiting
  • CHAL - Centre Hospitalier Alpes Léman
    Contamine-sur-Arve, France
    Not yet recruiting
  • Groupement Hospitalier Portes de Provence
    Montélimar, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.